José Antonio Allué, PhD
Head of Mass Spectrometry at Araclon Biotech-Grifols

Ph.D. (Pharmacy) University of Barcelona, Spain. Almost thirty years in the field of Biological Mass Spectrometry, eighteen of them dedicated to research in Alzheimer´s Disease by HPLC-MS/MS (MALDI, IMS-MS, Orbitrap-MS, reTOF-MS, TOF/TOF-MS, Ion-Trap-MS and Triple Quadrupole-MS). Applications of both, targeted and untargeted, proteomic techniques in the fields of immunology, metabolism, pharmacokinetics and pharmacodynamics. Applications of High-Mass MALDI Mass Spectrometry for the analysis of protein complexes and vaccines. Label-free shotgun proteomics by Travelling Wave Ion Mobility Spectrometry coupled to TOF-MS. ​

Participation
14th May, 2026
Plasma Aβ42/Aβ40 Identifies Early Amyloid Changes in PET Negative Individuals with Subjective Cognitive Decline